Science Bristol Myers Squibb and J&J Blood Thinner Fails Key Trial Phase A pivotal trial for a next-generation blood thinner developed by Bristol Myers Squibb and Johnson & Johnson has concluded unsuccessfully. The drug, known as... Editorial4 hours ago